Dr. Jamil R. Azzi, MD

Dr. Azzi practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Azzi's NPI, 1609061415, was assigned on September 14, 2007. Dr. Azzi graduated from Lebanese University School of Medicine in 2003. Dr. Azzi holds Massachusetts license L-231839.

Dr. Azzi's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Dr. Azzi's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Azzi is also affiliated with Massachusetts General Hospital. The medical group on file is Massachusetts General Physicians Organization (MGPO). Dmand AI also links Dr. Azzi to 3 more hospitals, 2 medical groups and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Azzi practices, 6 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Azzi's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Azzi is board certified in nephrology by the American Board of Internal Medicine. Dr. Azzi is licensed in Massachusetts.

Dmand AI lists chronic kidney disease, fluid and electrolyte imbalances, gout, kidney cysts and parathyroid gland disorder among the conditions Dr. Azzi treats.

CMS data shows 339 Medicare services from Dr. Azzi across 4 procedure codes in 2024, for 108 Medicare patients. Medicare paid $35,279 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 108 Medicare patients who saw Dr. Azzi in 2024. The largest group is under 65, with 46 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 43% are also on Medicaid. Their average risk score is 5.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Azzi's median patient age at 66, with 46% women.

In 2024, Dr. Azzi wrote 596 Medicare Part D claims for 60 patients. 91% of them were for generic drugs. CMS names the drug for 467 of them, across 19 drugs with 11 or more claims each, at $85,849 in total drug cost. In 2023, CMS named 447 claims across 20 drugs.

Dr. Azzi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Azzi as offering telehealth.

Dmand AI links 122 papers to Dr. Azzi, published from 2010 to 2025. 2020 was the busiest year, with 12. The most frequent topics are Graft Rejection, Kidney Transplantation and Graft Survival. Dr. Azzi has published most often in Am J Transplant. Dr. Azzi's most frequent co-authors are Zhabiz Solhjou, MD, Anil Kumar Chandraker, MBCHB and Marwan Mounayar, MD.

Dmand AI links Dr. Azzi to 2 clinical trials. Conditions studied include Rejection, Psychology and Social Behavior. Brigham and Women's Hospital sponsors the most, 2.

CMS Open Payments shows 68 general payments to Dr. Azzi from 16 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 69% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $25,486.

Dmand AI lists 5 awards for Dr. Azzi, most recently Basic Science Innovation Award in 2017. Dr. Azzi serves on Basic Science Community of Practice American Society of Transplantation.

Dr. Azzi graduated from Lebanese University School of Medicine in 2003. Dr. Azzi is a member of ADA, American Heart Association, ASN and American Society of Transplantation.

Dr. Azzi is in network with 15 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Blue Cross Blue Shield of Massachusetts. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.